SEC Filing Summary: Connexa Sports Technologies, Inc. (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Connexa Sports Technologies, Inc. (the "Company") on September 28, 2022. The filing discloses the entry into a Material Definitive Agreement and the unregistered sale of equity securities. The Company is a Delaware corporation with principal executive offices in Windsor Mill, MD.
Key Financial Metrics and Transaction Details
The Company completed a private placement offering (the "Offering") with a single institutional investor. Key transaction metrics include:
- Total Aggregate Proceeds: Approximately $5.0 million.
- Securities Issued:
- 1,018,510 shares of common stock.
- Pre-Funded Warrants to purchase 11,802,002 shares of common stock.
- 5-Year Warrants to purchase 12,820,512 shares at an exercise price of $0.39.
- 7.5-Year Warrants to purchase 25,641,024 shares at an exercise price of $0.43.
- Pricing: Common stock and associated warrants were sold at $0.39 per share; Pre-Funded Warrants were sold at $0.3899 per warrant.
- Placement Agent: Spartan Capital Securities LLC acted as the exclusive placement agent and received warrants to purchase up to 512,820 shares at $0.429 per share.
The filing text does not provide specific values for revenue, profit, cash flow, margins, or existing debt levels as this is a transactional report rather than a periodic financial statement.
Material Changes and Use of Proceeds
The primary material change is the significant increase in authorized and outstanding equity due to the issuance of common stock and warrants. The Company intends to use the net proceeds from the Offering for working capital purposes and to repurchase inventory.
Outlook, Risks, and Contingencies
- Registration Rights: The Company entered into a Registration Rights Agreement requiring the filing of a registration statement with the SEC no later than December 20, 2022, to cover the resale of the unregistered shares and shares issuable upon exercise of warrants.
- Exercisability: The Warrants and Pre-Funded Warrants will be exercisable only after stockholder approval is received and effective under Nasdaq rules.
- Variable Pricing: The Warrants issued in the Offering contain variable pricing features.
- Regulatory Status: The securities were sold under Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D and are not registered for public sale absent an applicable exemption.
Key Facts for Investor Verification
- Verify the status of the required stockholder approval needed to make the Warrants and Pre-Funded Warrants exercisable.
- Confirm the filing date and effectiveness of the registration statement required by December 20, 2022.
- Assess the dilution impact of the 1,018,510 shares issued plus the 38,461,536 shares underlying the various warrants.
- Review the specific terms of the variable pricing features in the Warrants as detailed in the attached exhibits.
- Monitor the Company's ability to utilize the $5.0 million proceeds for inventory repurchase and working capital as stated.